SEC Form 4 · accession 0001645627-17-000118
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 8, 2017
Accepted (ET)
Sep 14, 2017 · 3:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2017 | P | 5,000 | $0.0247 | A | 23,297,189 | D | |
| Common Stock | Sep 8, 2017 | P | 5,000 | $0.0254 | A | 23,302,189 | D | |
| Common Stock | Sep 8, 2017 | P | 3,000 | $0.0254 | A | 23,305,189 | D | |
| Common Stock | Sep 8, 2017 | P | 3,000 | $0.0252 | A | 23,308,189 | D | |
| Common Stock | Sep 8, 2017 | P | 5,000 | $0.0258 | A | 23,313,189 | D | |
| Common Stock | Sep 8, 2017 | P | 5,000 | $0.0258 | A | 23,318,189 | D | |
| Common Stock | Sep 8, 2017 | P | 5,000 | $0.0258 | A | 23,323,189 | D | |
| Common Stock | Sep 8, 2017 | P | 5,000 | $0.0259 | A | 23,328,189 | D | |
| Common Stock | Sep 11, 2017 | P | 5,000 | $0.0254 | A | 23,333,189 | D | |
| Common Stock | Sep 11, 2017 | P | 5,000 | $0.0245 | A | 23,338,189 | D | |
| Common Stock | Sep 11, 2017 | P | 5,000 | $0.0255 | A | 23,343,189 | D | |
| Common Stock | Sep 11, 2017 | P | 6,000 | $0.0255 | A | 23,349,189 | D | |
| Common Stock | Sep 11, 2017 | P | 5,000 | $0.0255 | A | 23,354,189 | D | |
| Common Stock | Sep 11, 2017 | P | 5,000 | $0.0255 | A | 23,359,189 | D | |
| Common Stock | Sep 11, 2017 | P | 5,000 | $0.0255 | A | 23,364,189 | D | |
| Common Stock | Sep 11, 2017 | P | 3,000 | $0.0256 | A | 23,367,189 | D | |
| Common Stock | Sep 11, 2017 | P | 5,000 | $0.0259 | A | 23,372,189 | D | |
| Common Stock | Sep 12, 2017 | P | 3,000 | $0.0256 | A | 23,375,189 | D | |
| Common Stock | Sep 12, 2017 | P | 3,000 | $0.0257 | A | 23,378,189 | D | |
| Common Stock | Sep 12, 2017 | P | 3,000 | $0.0257 | A | 23,381,189 | D |
Table II — derivative securities
No Table II lines on this filing.